MedPath

Erteberel

Generic Name
Erteberel
Drug Type
Small Molecule
Chemical Formula
C18H18O3
CAS Number
533884-09-2
Unique Ingredient Identifier
2ZUL6758TZ

Overview

Erteberel is an estrogen receptor beta agonist that has been used in trials studying the treatment of Benign Prostatic Hyperplasia.

Background

Erteberel is an estrogen receptor beta agonist that has been used in trials studying the treatment of Benign Prostatic Hyperplasia.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath